Lotus Eye Hospital and Institute Limited has informed the Exchange regarding 'Board comments on imposition of fine under Regulation 17(1A) of SEBI (LODR), 2015'.
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lotus Eye Hospital informed the exchanges that its Board, at a meeting on February 11, 2026, took on record a fine imposed by BSE and NSE for non-compliance with SEBI's Regulation 17(1A), which relates to appointment or reappointment of directors. The company argued that a change in designation of a director should not be treated as a new appointment, but the stock exchanges disagreed and treated the change in designation as equivalent to an appointment. The company submitted its reply to both exchanges and has already paid the fine, while reiterating its commitment to corporate governance and future compliance.
The matter is a minor technical compliance issue that has already been resolved with the fine paid. The financial impact on the company is likely negligible, and this is unlikely to have a material effect on the stock price. However, it signals a need for stricter compliance monitoring on board-level appointments.